Zhidao Biotech received RMB 100 million in Series C financing

Zhidao Biotechnology is a manufacturer of recombinant protein products, through the independent research and development of high-throughput protein renaturation screening and purification technology platform, fixed-point protein coupling design platform, high-throughput protein drug formulation development technology platform and other original technologies, research and development of recombinant protein products and drugs. Recently, Zhidao Biotechnology received RMB 100 million in Series C financing, led by Zhongguancun Science City, and participated by Hibiscus Capital and Infinity.

This article is transferred from: https://www.itjuzi.com/investevent/13752705
This site is only for collection, and the copyright belongs to the original author.